Viewing Study NCT02303769


Ignite Creation Date: 2025-12-24 @ 11:07 PM
Ignite Modification Date: 2025-12-25 @ 8:39 PM
Study NCT ID: NCT02303769
Status: COMPLETED
Last Update Posted: 2016-02-25
First Post: 2014-11-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTS
Sponsor: GL Pharm Tech Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module